Bharat Biotech commences direct supply of COVID-19 vaccine Covaxin to 14 States
The Hindu
Bharat Biotech has started supplying its COVID-19 treatment vaccine to the States based on the allocations received by the Central government
Bharat Biotech has commenced direct supply of its COVID-19 vaccine ‘Covaxin’ to 14 States, including Delhi and Maharashtra, with effect from May 1, according to the company’s Joint Managing Director Suchitra Ella. The Hyderabad-based firm has started supplying its COVID-19 treatment vaccine to the States based on the allocations received by the Central government. “Bharat Biotech confirms direct supplies of COVAXIN to the following State govt’s since 1/5/21, based on the allocations received by GoI. Requests have been received from other States, & will be processed for distribution based on availability of stocks 24x7,” Ms. Ella tweeted.More Related News

Insurance penetration and density are often misunderstood and do not reveal how many families are insured or whether they would be financially secure if the main earning member were to die. The real issue is not reach but adequacy, as households may have life insurance but not enough cover to replace lost income, leaving them financially vulnerable.












